Effect of plaque brachytherapy dose and dose rate on risk for disease-related mortality in 1238 patients with choroidal melanoma

Maria Filì, Eric Trocme, Christina Herrspiegel, Stefan Seregard, Gustav Stålhammar

Read More

Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm

Maria Filì, Eric Trocme, Louise Bergman, Thonnie Rose Ong See, Helder André, Katarina Bartuma, Leonard Girnita, Charlotta All-Eriksson, Stefan Seregard, Gustav Stålhammar

Read More

https://bjo.bmj.com/content/104/1/26

Multifocal iris melanoma in a 2-year-old managed with I-125 plaque brachytherapy

Andrew R. Lee, MD, Dilraj S. Grewal, MD, Thomas J. Cummings, MD, Laura B. Enyedi, MD, Nicole A. Larrier, MD, Prithvi Mruthyunjaya, MD

Read More

 

Vitrectomy and Vitrector Port Needle Biopsy of Choroidal Melanoma for Gene Expression Profile Testing Immediately before Brachytherapy

Deepthi M. Reddy, MD, Lauren B. Mason, BS, John O. Mason III, Jason N Crosson, Jacob J Yunker, MD

Read More

Malignant transformation of multifocal tapioca iris nevus in a child

Maxwell R. Harley, BA, Raksha Rao, MD, Sara E. Lally, MD, Carol L. Shields, MD

Read More

Pattern of Local Recurrence After I-125 Episcleral Brachytherapy for Uveal Melanoma in a Spanish Referral Ocular Oncology Unit

Sara Sánchez-Tabernero, Ciro García-Alvarez, Ma Fe Muñoz-Moreno, Patricia Diezhandino, Pilar Alonso-Martínez, Jesus M. de Frutos-Baraja, Francisco López-Lara, Maria A. Saornil

Read More